In addition, eIF4E knockdown reportedly decreases the breast cancer cell proliferation, and inhibition of MNK kinase activity by cercosporamide or CGP57380 effectively targets lung, prostate and breast cancer cells [7, 10–12]. This evidence concerns the gene EIF4E and breast cancer.